Purpose: Although serosal invasion is a critical predisposing factor for peritoneal dissemination in advanced gastric cancer, the accuracy of preoperative assessment using routine imaging studies is unsatisfactory. This study was conducted to identify high-risk group for serosal invasion using preoperative factors in patients with advanced gastric cancer. Materials and Methods: We retrospectively analyzed clinicopathological features of 3,529 advanced gastric cancer patients with Borrmann type I/II/III who underwent gastrectomy at Korea Cancer Center Hospital between 1991 and 2005. We stratified patients into low-(≤40%), intermediate-(40~70%), and high-risk (>70%) groups, according to the probability of serosal invasion. Results: Borrmann type, size, longitudinal and circumferential location, and histology of tumors were independent risk factors for serosal invasion. Most tumors of whole stomach location or encircling type had serosal invasion, so they belonged to high-risk group. Patients were subdivided into 12 subgroups in combination of Borrmann type, size, and histology. A subgroup with Borrmann type II, large size (≥7 cm), and undifferentiated histology and 2 subgroups with Borrmann type III, large size, and regardless of histology belonged to high-risk group and corresponded to 25% of eligible patients. Conclusions: This study have documented high-risk group for serosal invasion using preoperative predictors. And risk stratification for serosal invasion through the combination with imaging studies may collaboratively improve the accuracy of preoperative assessment, reduce the number of eligible patients for further staging laparoscopy, and optimize therapeutic strategy for each individual patient prior to surgery.
Introduction
Peritoneal metastasis, from gastric cancer, is the most typical non-curative factor in patients with advanced gastric cancer (AGC).
It commonly occurs when tumor cells are released into the abdominal cavity after the tumor is exposed, following serosal invasion.
(1-3) Except for the cases with severe peritoneal metastasis, such as carcinomatosis, as it is very difficult to diagnose peritoneal metastasis from gastric cancer via a preoperative examination on disease stage, peritoneal metastasis is often found during surgery for a radical gastrectomy. Thus, some researchers suggested that diagnostic laparoscopy should be conducted on all patients with AGC.
(4,5) However, an incidence rate of peritoneal metastasis is 4~23% in patients with AGC, which is relatively low; the conduct of diagnostic laparoscopy in all the patients wastes time and money (6) (7) (8) Thus, it is most desirable that patients with high risk of peritoneal metastasis should be selected before surgery among patients with enocarcinoma, mucinous adenocarcinoma, and other adenocarcinomas.
The subjects were classified into the negative group in which the tumor invasion was limited to the muscularis propria or subserosa (1,208 patients) , and the positive group with serosal invasion (2,321 patients), according to the presence of serosal invasion (visceral peritoneum or adjacent structure), and then the correlation of clinicopathological parameters that can be assessed before surgery with serosal invasion was analyzed. In addition, after the subjects were classified via the combination of the statistically significant risk factors of serosal invasion, the positive rate of serosal invasion was examined for each group. The subjects were classified into the lowrisk, intermediate-risk, and high-risk groups if the positive rate of serosal invasion ≤40%, 40~70%, and ＞70%, respectively, followed by stratification, according to serosal invasion risk. In addition, the overall survival curve was compared, among the 3 groups. For the follow-up of the patients, interview, physical examination, tumor markers, plain chest X-ray and abdominal CT were conducted every 3~4 months, for 2 years after the surgery; and thereafter, they were conducted every 6 months. Gastric endoscopy or upper gastrointestinal series was conducted at least once a year. Followup period, death, and reasons for death were examined using the patient's medical records and statistics, such as the Korea cancer registry program.
A statistical analysis was conducted, using SPSS for Window version 13.0 (SPSS Inc., Chicago, IL, USA). A Chi-square test was used for univariate analysis of nominal variables, and logistic regression was used for multivariate analysis. A survival analysis was conducted, using the Kaplan-Meier survival curve and Log-rank test. If P＜0.05, it was considered statistically significant.
Results

Correlation of clininopathological parameters with serosal invasion in AGC
Univariate and muitivariate analysis showed that among the clinicopathological parameters, the Borrmann type, tumor size, tumor's longitudinal and horizontal location, and histologic grade had a statistically significant correlation with serosal invasion by tumor; however, the patient's gender and age had no correlation with serosal invasion (Table 1 , 2).
Of the total 3,529 patients, the serosal invasion rate was shown to be 46.2% in patients with Borrmann I type (n=130, 3.7%), 62.9% in patients with Borrmann II type (n=1,114. 31.6%), and 68.3% in patients with Borrmann III type (n=2,285, 64.7%), which showed that the serosal invasion rate was high in patients with Borrmann II and III. The odd ratio of serosal invasion was shown to be 2.3-fold and 3.1-fold higher in patients with Borrmann II and III, respectively, than in the patients with Borrmann I type. In addition, when patients were divided into the 2 groups, according to the reference tumor size of 7 cm, and the serosal invasion rate was then compared between the 2 groups, the serosal invasion rate was shown to be 58.2% in the group with tumor size ＜7 cm and 81.9% in the group with tumor size ≥7 cm. Furthermore, the odd ratio of serosal invasion was also shown to be 3.1-fold higher in the group with tumor size ≥7 cm than in the group with tumor size ＜7 cm.
When the serosal invasion rate was compared, according to the longitudinal location of the tumor, no significant difference was found, according to the location of the upper, middle, and lower location. However, most of the patients with the whole type, which invades the 3 areas from the upper to the lower stomach, and comprises only 1.5% (54 cases) of the total patients, showed serosal invasion positivity. Meanwhile, when the serosal invasion rate was compared according to the horizontal location of the tumor, no significant difference was found, according to the location of lesser curvature, anterior, greater curvature, and posterior. However, it was shown to be 85.3% in the patients with encircling type, which was significantly higher than that of other tumors, and the odd ratio was also shown to be 2.5-fold higher in patients with encircling type than in patients with other types. When the serosal invasion rate was compared according to histologic classification of tumor, it was shown to be 61.1% in the patients with differentiated type and 69.9% in the patients with undifferentiated type, which showed a statistically significant difference, despite an odd ratio of 1.2-folds.
Classification of serosal invasion risk in AGC
After the subjects were classified via the combination of the statistically significant risk factors of serosal invasion, the positive rate of serosal invasion was examined in each group. However, as the serosal invasion rate was 94.4% and 85.3% in patients with whole type and patients with encircling type, respectively, which were very high, they were assigned to the high risk group by a single factor. The subjects were classified according to the combination of three factors: Borrmann type, tumor size, and histologic grade, and then the serosal invasion rate of each group were examined (Table 3) .
Each group was classified into the following; low-risk, intermediate-risk, and high-risk groups according to the positive rate of serosal invasion ≤40%, 40~70%, and ＞70%, respectively (Fig.   1 ). The serosal invasion rate was shown to be 21~32% in the group with tumor size ＜7 cm and Borrmann I type, corresponding to the low risk group. Meanwhile, it was shown to be 84~87% in the group with tumor size ≥7 cm and Borrmann III type and group with tumor size ≥7 cm, Borrmann II type, and undifferentiated type, which corresponded to the high risk group. The classification of serosal invasion risk showed that 25% of the total patients corresponded to the high risk group. In addition, when the overall survival curve was compared via the comparison of prognosis among the three groups, a poor prognosis was shown in the high risk, intermediate risk, and low risk groups, in that order (Fig. 2) . Values are presented as number (%).
Discussion
Peritoneal metastasis has been known to be the most common non-curative factor in patients with AGC. An incidence rate of In this study, a new approach that diagnoses serosal invasion in patients with AGC was explored. The results of this study showed that a significant correlation was found between clinicopathological parameters that can be assessed before the surgery and serosal invasion, and that the serosal invasion risk was stratified into the low-, intermediate-, and high-risk groups, via the combination of the predictors of serosal invasion. However, the prediction of serosal invasion, using the criteria of the high risk group, had 32.6% sensitivity and 89.7% specificity, which were not high enough.
Thus, this method was shown to be inappropriate for diagnosing serosal invasion.
On the contrary, if diagnostic laparoscopy is selectively applied to the serosal invasion, high-risk group among patients with AGC, when the aforementioned stratification is applied to clinical practices, the frequency of conducting diagnostic laparoscopy is expected to decrease by 25%. If the conventional radiologic evalua- Fig. 3 . Diagnostic and treatment approach in patients with advanced gastric cancer (AGC).
